$10 Billion Deal, page-6784

The 23rd International AIDS Conference (AIDS 2020: Virtual) is less than two weeks away. Here are some of the late-breaking scientific highlights you can expect at the conference, featuring highly anticipated research results on the year’s most pressing topics.

Late-breaking highlights

• The latest global HIV estimates from UNAIDS
• A survey of LGBTI+ people in 138 countries assessing the socioeconomic impact of COVID-19
• An update from the Tsepamo study examining whether neural tube defects are associated with dolutegravir-based HIV treatment
• New data from the ADVANCE trial comparing multidrug antiretroviral therapies
• A look at the impact of COVID-19 on PrEP care at a Boston hospital
• New evidence on what may be the first adult with HIV achieving long-term HIV remission without a bone marrow transplant
• Analysis of the safety and efficacy of the first long-acting injectable PrEP

Take part in the world’s largest 24-hour virtual conference on HIV and register with reduced rates today. Find out more and get involved in AIDS 2020: Virtual here!

Wondering if that would be BIT225 (black highlight) ?